Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

SELL
$0.16 - $0.31 $3,474 - $6,732
-21,718 Reduced 59.57%
14,737 $2,000
Q2 2022

Aug 11, 2022

SELL
$0.24 - $1.2 $13,078 - $65,394
-54,495 Reduced 59.92%
36,455 $9,000
Q1 2022

May 12, 2022

SELL
$0.94 - $2.38 $80,230 - $203,137
-85,352 Reduced 48.41%
90,950 $109,000
Q4 2021

Feb 11, 2022

BUY
$1.89 - $3.12 $181,062 - $298,896
95,800 Added 119.0%
176,302 $457,000
Q3 2021

Nov 12, 2021

BUY
$2.34 - $3.77 $180,180 - $290,290
77,000 Added 2198.74%
80,502 $188,000
Q2 2021

Aug 10, 2021

SELL
$3.48 - $4.45 $12,239 - $15,650
-3,517 Reduced 50.11%
3,502 $13,000
Q1 2021

May 12, 2021

BUY
$3.57 - $6.2 $2,363 - $4,104
662 Added 10.41%
7,019 $26,000
Q4 2020

Feb 10, 2021

BUY
$4.4 - $7.32 $13,398 - $22,289
3,045 Added 91.94%
6,357 $33,000
Q3 2020

Nov 12, 2020

BUY
$4.38 - $8.35 $14,506 - $27,655
3,312 New
3,312 $17,000
Q2 2020

Aug 13, 2020

SELL
$3.64 - $9.26 $51,688 - $131,492
-14,200 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$2.54 - $9.38 $105,222 - $388,575
-41,426 Reduced 74.47%
14,200 $56,000
Q4 2019

Feb 10, 2020

BUY
$7.07 - $9.51 $177,216 - $238,377
25,066 Added 82.02%
55,626 $529,000
Q3 2019

Nov 12, 2019

BUY
$7.77 - $11.26 $193,325 - $280,160
24,881 Added 438.12%
30,560 $237,000
Q2 2019

Aug 09, 2019

BUY
$7.91 - $10.25 $44,920 - $58,209
5,679 New
5,679 $53,000
Q1 2019

May 13, 2019

SELL
$6.0 - $11.07 $4,884 - $9,010
-814 Closed
0 $0
Q4 2018

Feb 06, 2019

BUY
$5.81 - $7.89 $4,729 - $6,422
814 New
814 $5,000
Q3 2018

Nov 08, 2018

SELL
$6.57 - $8.31 $40,352 - $51,040
-6,142 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$3.93 - $8.93 $24,138 - $54,848
6,142 New
6,142 $49,000

Others Institutions Holding QTNT

# of Institutions
1
Shares Held
1.71K
Call Options Held
0
Put Options Held
0

About Quotient Ltd


  • Ticker QTNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Description
  • Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...
More about QTNT
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.